View graph of relations
  1. 2017
  2. Published
  3. 2015
  4. Published
  5. Published
  6. Published
  7. 2014
  8. Published
  9. 2013
  10. Published
    Anink, J., Otten, M. H., Gorter, S. L., Prince, F. H. M., van Rossum, M. A. J., van den Berg, J. M., ... van Suijlekom-Smit, L. W. A. (2013). Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab? Rheumatology, 52(9), 1674-1679. https://doi.org/10.1093/rheumatology/ket170
  11. Published
    Anink, J., Otten, M. H., Prince, F. H. M., Hoppenreijs, E. P. A. H., Wulffraat, N. M., Swart, J. F., ... van Suijlekom-Smit, L. W. A. (2013). Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register. Rheumatology, 52(4), 712-717. https://doi.org/10.1093/rheumatology/kes373
  12. 2012
  13. Published
  14. Published
  15. Published
  16. 2011
  17. Published
    Otten, M. H., Prince, F. H. M., Armbrust, W., ten Cate, R., Hoppenreijs, E. P. A. H., Twilt, M., ... van Suijlekom-Smit, L. W. A. (2011). Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis. JAMA-Journal of the American Medical Association, 306(21), 2340-2347. https://doi.org/10.1001/jama.2011.1671
  18. Published
    Otten, M. H., Prince, F. H. M., Twilt, M., ten Cate, R., Armbrust, W., Hoppenreijs, E. P. A. H., ... van Suijlekom-Smit, L. W. A. (2011). Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis - Data from the Dutch Arthritis and Biologicals in Children Register, 1999-2010. Journal of Rheumatology, 38(10), 2258-2263. https://doi.org/10.3899/jrheum.110145
  19. Published
    Prince, F. H. M., de Bekker-Grob, E. W., Twilt, M., van Rossum, M. A. J., Hoppenreijs, E. P. A. H., ten Cate, R., ... van Suijlekom-Smit, L. W. A. (2011). An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register. Rheumatology, 50(6), 1131-1136. https://doi.org/10.1093/rheumatology/keq432
  20. Published
    Otten, M. H., Prince, F. H. M., ten Cate, R., van Rossum, M. A. J., Twilt, M., Hoppenreijs, E. P. A. H., ... van Suijlekom-Smit, L. W. A. (2011). Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective? Annals of the Rheumatic Diseases, 70(2), 337-340. https://doi.org/10.1136/ard.2010.135731
  21. Published
  22. Published
  23. 2010
  24. Published
  25. Published
    Smolen, J. S., Landewe, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., ... van der Heijde, D. (2010). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases, 69(6), 964-975. https://doi.org/10.1136/ard.2009.126532
  26. Published
    Otten, M. H., Prince, F. H. M., Twilt, M., van Rossum, M. A. J., Armbrust, W., Hoppenreijs, E. P. A. H., ... van Suijlekom-Smit, L. W. A. (2010). Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept. Journal of Rheumatology, 37(3), 665-667. https://doi.org/10.3899/jrheum.090550
  27. Published
  28. Published
  29. 2003
  30. Published